Showing results (221-230 of 260) with videos related to
Sort By:
Pageof 26
Biorxiv : the Preprint Server for Biology|March 3, 2023
Human APOBEC3B promotes tumor heterogeneity in vivo including signature mutations and metastasesCameron Durfee, Nuri Alpay Temiz, Rena Levin-Klein, et al.Genome Research|September 13, 2012
Extensive somatic L1 retrotransposition in colorectal tumorsSzilvia Solyom, Adam D Ewing, Eric P Rahrmann, et al.Mbio|April 26, 2022
Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 Mpro/3CLpro in Living CellsSeyed Arad Moghadasi, Morgan A Esler, Yuka Otsuka, et al.Science Advances|December 3, 2025
Virus-induced APOBEC3 transmutagenesis in bladder cancer initiationGeorge H Hatton, Sally R James, Andrew S Mason, et al.SLAS Discovery : Advancing Life Sciences R & D|August 22, 2024
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screeningRenee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.Nature|February 8, 2013
APOBEC3B is an enzymatic source of mutation in breast cancerMichael B Burns, Lela Lackey, Michael A Carpenter, et al.Cell Reports. Medicine|October 5, 2023
Human APOBEC3B promotes tumor development in vivo including signature mutations and metastasesCameron Durfee, Nuri Alpay Temiz, Rena Levin-Klein, et al.Plos Pathogens|September 11, 2020
A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humansYusuke Nakano, Keisuke Yamamoto, Mahoko Takahashi Ueda, et al.ACS Chemical Biology|December 21, 2011
First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3GMing Li, Shivender M D Shandilya, Michael A Carpenter, et al.Science Advances|October 13, 2016
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancerEmily K Law, Anieta M Sieuwerts, Kelly LaPara, et al.Pageof 26